血清TDP-43与心脏骤停自主循环恢复后短期神经功能不良结局相关
本研究纳入2023年1月至12月心脏骤停自主循环恢复(ROSC)患者92例,按28天脑功能分类评分分为神经功能良好组51例和不良组41例。ROSC后24小时测定血清TDP-43、肿瘤坏死因子-α、白细胞介素-6和10、C反应蛋白及神经元特异性烯醇化酶(NSE)。不良神经功能结局组血清TDP-43显著高于良好组(P<0.05)。多因素logistic回归显示TDP-43、目击骤停、IL-6和NSE与28天不良神经功能结局相关(均P<0.05)。限制性立方样条提示TDP-43血清水平11.64 pg/mL可能是区分良好与不良神经功能结局的理想截断值;TDP-43的AUC=0.78,接近NSE的AUC=0.82。研究构建并验证了联合TDP-43、目击骤停、IL-6和NSE的动态列线图预测模型。
要点
- 心脏骤停ROSC后24小时血清TDP-43在28天神经功能不良组显著高于良好组(P<0.05)。
- 多因素logistic回归显示TDP-43、目击骤停、IL-6和NSE与28天不良神经功能结局相关(均P<0.05)。
- 限制性立方样条提示血清TDP-43水平11.64 pg/mL可能是区分良好与不良神经功能结局的理想截断值。
- 血清TDP-43的AUC=0.78,接近血清NSE的AUC=0.82。
- 联合TDP-43、目击骤停、IL-6和NSE的动态列线图预测模型已构建并验证。
适用人群与场景
- 心脏骤停后自主循环恢复(ROSC)的患者,研究于2023年1月至12月纳入。
诊断标准与关键阈值
- 神经功能采用ROSC后28天脑功能分类评分评估。
- 限制性立方样条分析提示血清TDP-43水平11.64 pg/mL可能是区分良好与不良神经功能结局的理想截断值。
研究设计与关键结果
- 研究纳入92例心脏骤停ROSC患者,神经功能良好组51例、不良组41例。
- ROSC后24小时测定血清TDP-43、肿瘤坏死因子-α、白细胞介素-6和10、C反应蛋白及神经元特异性烯醇化酶(NSE)。
- 不良神经功能结局组血清TDP-43显著高于良好组(P<0.05)。
- 单因素和多因素logistic回归分析显示TDP-43、目击骤停、IL-6和NSE与28天不良神经功能结局相关(均P<0.05)。
- 限制性立方样条分析提示血清TDP-43水平11.64 pg/mL可能是区分良好与不良神经功能结局的理想截断值。
- 血清TDP-43的AUC=0.78,接近血清NSE的AUC=0.82。
- 构建并验证了联合TDP-43、目击骤停、IL-6和NSE的动态列线图预测模型。
证据类型、等级与局限
- 证据类型:研究论文(单中心队列研究,原文未报告局限性)。
对床旁实践的改变
- 作者认为,升高的血清TDP-43水平与心脏骤停ROSC后28天不良神经功能结局相关,可与目击骤停、IL-6和NSE联合用于预测不良结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objective : To explore the association of serum transactive response DNA binding protein 43 (TDP-43) with 28-day poor neurologic outcome in patients with return of spontaneous circulation (ROSC) after cardiac arrest. Methods : We performed a study between January and December 2023. Eligible patients with ROSC following cardiac arrest were enrolled. Their baseline characteristics were collected, and serum levels of TDP-43, tumor necrosis factor-α, interleukin-6 and 10, C-reactive protein, and neuron-specific enolase (NSE) at 24 h after ROSC were measured. The neurologic function was assessed by the cerebral performance category scores on day 28 after ROSC. Results : A total of 92 patients were included, with 51 and 41 patients in the good and poor neurologic outcome groups, respectively. Serum TDP-43 was significantly higher in the poor than the good neurologic outcome group ( P < 0.05). Univariate and multivariate logistic regression analyses showed that TDP-43, Witnessed CA, IL-6, and NSE were associated with poor 28-day neurologic outcome (all P < 0.05). Restricted cubic spline analysis revealed that TDP-43 at the serum level of 11.64 pg/mL might be an ideal cutoff value for distinguishing between good and poor neurologic outcomes. Area under curve of serum TDP-43 (AUC = 0.78) was close to that of serum NSE (AUC = 0.82). A dynamic nomogram prediction model that combined TDP-43, Witnessed CA, IL-6, and NSE was constructed and validated. Conclusion : Elevated serum TDP-43 level was associated with and could be used together with Witnessed CA, IL-6, and NSE to predict poor 28-day neurologic outcome in patients after ROSC following cardiac arrest.
参考来源
- Sun Z, Yu D, Li P, et al. SERUM TRANSACTIVE RESPONSE DNA BINDING PROTEIN 43 ASSOCIATES WITH POOR SHORT-TERM NEUROLOGIC OUTCOME AFTER RETURN OF SPONTANEOUS CIRCULATION FOLLOWING CARDIAC ARREST. Shock. 2024. PMID: 38813918. doi:10.1097/SHK.0000000000002378
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。